HYPOXIA-INDUCIBLE FACTOR AS A MOLECULAR TARGET IN HEPATORENAL SYNDROME

被引:0
|
作者
Virstyuk, N. G. [1 ]
Slyvka, N. A. [2 ]
机构
[1] Ivano Frankivsk Natl State Med Univ, Int Ukrainian Univ, Ivano Frankivsk, Ukraine
[2] Bukovinian State Med Univ, Inst Internal Affairs Ukraine, Chernovtsy, Ukraine
来源
WORLD OF MEDICINE AND BIOLOGY | 2018年 / 65卷 / 03期
关键词
hepatorenal syndrome (HRS); alcoholic liver cirrhosis (ALC); hypoxia-inducible factor; hepatic renal failure;
D O I
10.26724/2079-8334-2018-3-65-23-28
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hepatorenal syndrome (HRS) is a serious complication of alcohol liver cirrhosis (ALC). Studying of the mechanisms of molecular response to hypoxia in HRS is a promising direction of research in hepatology. The aim of present study was to evaluate the role of hypoxia-inducible factor HIF-1 alpha in the pathogenesis of HRS at the acute-on-chronic (ACLF) liver failure (CLF) in patients with ALC. 150 patients with ALC+ HRS were divided into 2 groups: I group (n= 67) -CLF,II group(n= 83) - ACLF. Level of HIF-1 alpha in the most severe category of patients in group 2, with stage IV by CLIF-C-ACLF scale, was almost three times higher than that of a similar category in group 1, with Child-Pugh C class, and was 30 +/- 7,9 ng/ml. Dramatic increase of HIF-1a level in the group 2 patients with the IV stage by CLIF-C-ACLF scale confirms the severe tissue hypoxia, which is caused by a significant deterioration of the splanchnic blood flow and spasm of renal vessels at the HRS. HIF-1 alpha levels closely correlate with the indicators of hepatic and renal failure in the patients with ALC+HRS, which allows to use it as an indicator for comprehensive diagnosis of this disease.
引用
收藏
页码:23 / 28
页数:7
相关论文
共 50 条
  • [21] Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis
    Hua, Susan
    Dias, Thilani H.
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [22] Inhibitor of nuclear factor-kappaB alpha derepresses hypoxia-inducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1α
    Shin, Dong Hoon
    Li, Shan Hua
    Yang, Seung-Won
    Lee, Byung Lan
    Lee, Myung Kyu
    Park, Jong-Wan
    FEBS JOURNAL, 2009, 276 (13) : 3470 - 3480
  • [23] The human side of hypoxia-inducible factor
    Smith, Thomas G.
    Robbins, Peter A.
    Ratcliffe, Peter J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (03) : 325 - 334
  • [24] Hypoxia-inducible Factor Crosses the Checkpoint
    Lauer, Victoria
    Schoedel, Johannes
    EUROPEAN UROLOGY, 2016, 70 (04) : 633 - 634
  • [25] HYPOXIA-INDUCIBLE FACTOR AND PHYSICAL ACTIVITY
    Calderon Velez, Juan Camilo
    IATREIA, 2007, 20 (02) : 160 - 166
  • [26] Hypoxia-inducible factor 1.
    Zhang, JF
    Chen, GH
    Tang, J
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 1998, 25 (02) : 101 - 103
  • [27] Hypoxia-Inducible Factor in Thyroid Carcinoma
    Burrows, Natalie
    Babur, Muhammad
    Resch, Julia
    Williams, Kaye J.
    Brabant, Georg
    JOURNAL OF THYROID RESEARCH, 2011, 2011
  • [28] Endothelins and hypoxia-inducible factor in cancer
    Grimshaw, M. J.
    ENDOCRINE-RELATED CANCER, 2007, 14 (02) : 233 - 244
  • [29] Biochemistry of the hypoxia-inducible factor hydroxylases
    Fiorini, Giorgia
    Schofield, Christopher J.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2024, 79
  • [30] Hypoxia-inducible factor as a physiological regulator
    Maxwell, PH
    EXPERIMENTAL PHYSIOLOGY, 2005, 90 (06) : 791 - 797